Related Experiment Videos
Kidney cancer: current management guidelines
Frank Lee1, Hitendra R H Patel
1Institute of Urology and Nephrology, University College London, London W1W 7EY.
Hospital Medicine (London, England : 1998)
|May 9, 2002
Abstract:
Renal cell carcinoma accounts for 2% of all cancers. Medical progress has improved the outcome of early but not advanced disease. This article highlights the current practice for the management of renal cell carcinoma.
Insights
Renal cell carcinoma (RCC) is a common cancer, but treatments only improve early-stage outcomes. This review covers current RCC management strategies for better patient care.
Area of Science:
- Oncology
- Urology
Background:
- Renal cell carcinoma (RCC) represents 2% of all cancer diagnoses.
- Despite medical advancements, outcomes for advanced RCC have not significantly improved.
- Early-stage RCC management has seen better results.
Purpose of the Study:
- To provide an overview of the current practices in managing renal cell carcinoma.
- To highlight recent advancements and ongoing challenges in RCC treatment.
Main Methods:
- Review of current clinical guidelines and literature.
- Synthesis of established and emerging treatment modalities for RCC.
- Focus on diagnostic and therapeutic strategies.
Main Results:
- Early-stage RCC demonstrates improved patient outcomes with current treatments.
- Advanced-stage RCC continues to pose significant management challenges.
- Multidisciplinary approaches are crucial for optimal RCC care.
Conclusions:
- Current management strategies for renal cell carcinoma are effective for early-stage disease.
- Further research and novel therapies are needed for advanced RCC.
- This article summarizes the contemporary landscape of RCC management.